BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for HARMONY BIOSCIENCES · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · $50,000.00 income · posted Apr 15, 2026

Lobbying activity 1

Health Issues

Issues related to the development and approval of therapies for rare diseases Pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.